The Key Topics of Angine BD Online Webinars in the last 6 months

2022-03-21 18:11:44

The online Webinar of  " Health and Pharma partner" of Angine Forum has hold 10 sessions since August, 2021.


 

In the 10 seminars, a total of 35 speakers and more than 1000 Chinese BD and investment colleauges from more than 500 companies participated the in-depth discussions on the topic of international BD cooperation in bio&Pharma, from the internationalization strategy of pharmas, to the screening and evaluation of innovative projects, and global licensing and BD partnership.

 

Here is the list of all topics and panelists in the past 10 seminars forums hold by Angine " Health and Pharma partner ".

 

Please keeping follow and subscribe our Wechat platform " Health and Pharma partner " and Angine website, to get in later discussions and project cooperation and exchanges on the topic of "Biotech, Medtech and Pharma Companies' Global BD Partnership".

 

The first online seminar on " Health and Pharma partner " of Angine Forum:

公众号图片1.jpg

Date/Time: August 21, 2021

Theme: Is the internationalization strategy of Chinese pharmaceutical companies "reasonable" or "groundless"?

Panelist: 

Mr. Wang Xuegong, Executive Vice President of China Pharmaceutical Enterprise Management Association

Mr. Du Chen, Senior pharmaceutical strategy specialist

Mr. Meng Bayi, Senior pharmaceutical strategy and US market research specilaist

 

The second online seminar on " Health and Pharma partner " of Angine Forum:

医健国际化在线研讨会第二期-20210904.jpg

Date/Time: September 4, 2021

Theme: Pharmaceutical International BD, "What to choose" and "How to choose"?

Panelist: 

Dr. Dai Han, the commercial officer chief of Viva Biotech and the head of Viva Biotech Innovation Center

Dr. Xie Renzong, Senior Vice President of Pharmacology and Toxicology of Longchang Pharmaceuticals

Dr. Xiuyan Li, Founding Partner and President of PharmaSynergy

Dr. Xu Yanan, senior BD specialist

 

The Third online seminar on " Health and Pharma partner " of Angine Forum:

医健国际化在线研讨会第三期.jpg

Date/Time: September 29, 2021

Theme: ICH regulations, what you "know" and "don't know"?

Panelist:  

Dr. Cao Jiaxiang, Chinese-American, senior pharmaceutical preparation specialist 

Dr. Tao Peng, Ph.D., Institute of Chemistry, Chinese Academy of Sciences, Senior Engineer

Ms. Yang Airong, Quality Director of Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd

 

The 4th online seminar on " Health and Pharma partner " of Angine Forum:

医健国际化在线研讨会第四期.jpg

Date/Time: October 31, 2021

Theme: Risk management of pharmaceutical MAH, international perspective and local experience

Panelist:

Mr. Gao Yuhang, General Manager of Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd., Bachelor of Engineering, Senior Engineer

Mr. Chen Xiaobao, Founder and CEO of Shengdi Biopharmaceutical (Suzhou) Co., Ltd.

Mr. Peng Xinwen, Deputy Manager of International Business Department of Shandong Xinhua Pharmaceutical Co., Ltd.

Mr. Yan Sen, Mr. Yan Sen, Deputy Director of Life Science, WTW

 

The 5th Online Seminar on " Health and Pharma partner " of Angine Forum:

BD合作.jpg

Date/Time: November 24, 2021

Theme: European licensing and BD cooperation opportunities for Chinese biopharmaceuticals

Panelist: 

Dr. Ahmed Bouzidi, MB, former President of the European Biomedical Association

Dr. Amit Salvi, Director of PLG Preclinical and Clinical Operations

Dr. Jerome Coupe, Head of CMC and Quality Management, PLG Group, France

Prof. Jean-Jacques Zambrowski, MD, PLG/Juuka Partner – licensing-in

Dr Prashanth BSB, Head of Pharmacovigilance and Medical Affairs at PLG

 

The 6th online seminar on " Health and Pharma partner " of Angine Forum:

第六期.jpg

Date/Time:January 12, 2022

Theme:Pharma International BD and Investment, Core Elements of IP and Patent Evaluation

Panelist:

Ms. Wang Xuhong (Sunny Wang), Chief Commercial Officer and Head of Intellectual Property of GeneQuantum Healthcare Co., Ltd.

Ms. Li Caihui, Deputy General Manager of King Shing Capital, a tutor of master students of pharmaceutical intellectual property rights of Shanghai Institute of Biological Sciences, Chinese Academy of Sciences, and a member of the Professional Committee of Pharmaceutical Intellectual Property of Chinese Pharmaceutical Association

Dr. Kunpeng Peng, Beijing Unitalen Intellectual Property Partner and Director of Export Patent Department, Patent Attorney, Litigation Attorney, and Practising Trainer of All China Patent Attorneys Association

 

The 7th online seminar  on " Health and Pharma partner " of Angine Forum:

医健国际化在线研讨会第七期.jpg

Date/Time: February 16, 2022

Theme:  Key points of data security management and evaluation in international BD and investment projects

Panelist: 

Mr. Xu Aimin, BD Manager of iDeals solution Greater China

Mr. Luo Shizhong, founder of Angine Biotechnology and founder of " Health and Pharma partner " Alliance

 

The 8th online seminar on " Health and Pharma partner " of Angine Forum:

医健国际化在线研讨会第八期.jpg

Date/Time:  February 26, 2022

Theme:  BD and investment in pharmaceutical international, alliance management before and after project

Panelist:  

Dr. Zhou Feng, Head of BD Business of Haisco Pharmaceutical Group

Ms. Ma Yan, Executive Director of Business Development of Simcere Pharma

Mr. Xie Enwei, Senior Investment Director of Fosun Pharm

Ms. Zhou He, Deputy Director of BD of Simcere Pharma

 

The 9th online seminar on " Health and Pharma partner " of Angine Forum:

医健国际化在线研讨会第9期.jpg

Date/Time:  March 12, 2022

Theme:  International BD Cooperation in Biomedicine, Screening and Value Evaluation of Innovative Projects

Panelist:   

Prof. Hu Yuanjia, Associate Professor and Director of the Medicine Management Program, Institute of Chinese Medicine, University of Macau

Dr. Li Ming, Vice Chairman of the Innovation R&D Service Professional Committee of China Pharmaceutical Innovation Promotion Association

Mr. Hua Yuzhong, Head of BD of Harbin Pharmaceutical Group

 

The 10th online seminar on " Health and Pharma partner " of Angine Forum:

10期.jpg

Date/Time:  March 24, 2022

Theme:Life Sciences Webinar Series: Building Resilience into your Supply Chain

Panelist:

Frederick Gentile Director of Risk Engagement, WTW

Paul McLarnon Corporate Development Director, Sedgwick Group

Charles McCammon Team Leader Marine Risk Consulting and Claims Advocacy Practice Group, WTW

Gary Lynch Supply Chain Risk Leader, WTW

Daniel Green Property Broker, WTW

 

If you want to join Angine  " Health and Pharma partner " Alliance or participate in the later online seminars and " Health and Pharma partner "  BD offline training camp and workshop as the speaker/project roadshow presentor or the Alliance member to discuss the partnership opportunities with Chinese biotech and pharma companies, you can contact Tina Zhang who is the chief of information and event of Angine  " Health and Pharma partner " Alliance , Tina's email address is tinazhang@anginebio.com.

 

We are looking forward to inviting you to join our regularly online and offline meetings and webinars to discuss the international BD cooperation opportunities with Chinese big pharma and investors in this booming biotech and medtech innovation fileld.